Announcement
We are thrilled to announce that Vilin Bio Med Limited has officially signed a collaboration agreement with Ballard Partners, one of the most respected government relations and public affairs firms in the United States.
This partnership marks a significant milestone in Vilin Bio Med’s global expansion journey.
🤝 With the strategic support of Ballard Partners, Vilin Bio Med aims to: 🔹 Expand operations across the USA and GCC markets
🔹 Introduce patented and rare medicines to India at affordable prices, focusing on: • Cystic Fibrosis
• Thalassemia
• Monoclonal Antibodies (MABs)
• Stem Cell Therapies
💊 We are also working to be listed as a vendor with Walgreens and CVS Pharmacies, enabling streamlined access to quality products from India.
🧠 In parallel, Vilin Bio Med is exploring strategic acquisitions in the U.S. within: • Pharmacovigilance (PV)
• Regulatory Affairs
• Medical Billing Services
This partnership with Ballard Partners strengthens our vision to build a robust healthcare bridge between India and the global market.
🌐 Together, we’re setting the stage for impactful innovation, accessibility, and sustainable growth.
